Report Detail
Global Herceptin Biosimilar Sales Market Report 2021
- RnM2414048 |
- 16 June, 2021 |
- Global |
- 137 Pages |
- QYResearch |
- Pharma & Healthcare
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
Market Analysis and Insights: Global Herceptin Biosimilar Market
The global Herceptin Biosimilar market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Herceptin Biosimilar Scope and Market Size
The global Herceptin Biosimilar market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
Segment by Application
Hospital & Clinics
Oncology Centers
Other
The Herceptin Biosimilar market is analysed and market size information is provided by regions (countries). Segment by Application, the Herceptin Biosimilar market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil
1 Herceptin Biosimilar Market Overview
- 1.1 Herceptin Biosimilar Product Scope
- 1.2 Herceptin Biosimilar Segment by Type
- 1.2.1 Global Herceptin Biosimilar Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Breast Cancer
- 1.2.3 Colorectal Cancer
- 1.2.4 Leukemia
- 1.2.5 Lymphoma
- 1.2.6 Other
- 1.3 Herceptin Biosimilar Segment by Application
- 1.3.1 Global Herceptin Biosimilar Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Hospital & Clinics
- 1.3.3 Oncology Centers
- 1.3.4 Other
- 1.4 Herceptin Biosimilar Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Herceptin Biosimilar Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Herceptin Biosimilar Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Herceptin Biosimilar Price Trends (2016-2027)
2 Herceptin Biosimilar Estimates and Forecasts by Region
- 2.1 Global Herceptin Biosimilar Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Herceptin Biosimilar Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Herceptin Biosimilar Sales Market Share by Region (2016-2021)
- 2.2.2 Global Herceptin Biosimilar Revenue Market Share by Region (2016-2021)
- 2.3 Global Herceptin Biosimilar Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Herceptin Biosimilar Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Herceptin Biosimilar Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Herceptin Biosimilar Estimates and Projections (2016-2027)
- 2.4.2 Europe Herceptin Biosimilar Estimates and Projections (2016-2027)
- 2.4.3 China Herceptin Biosimilar Estimates and Projections (2016-2027)
- 2.4.4 Japan Herceptin Biosimilar Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Herceptin Biosimilar Estimates and Projections (2016-2027)
- 2.4.6 India Herceptin Biosimilar Estimates and Projections (2016-2027)
3 Global Herceptin Biosimilar Competition Landscape by Players
- 3.1 Global Top Herceptin Biosimilar Players by Sales (2016-2021)
- 3.2 Global Top Herceptin Biosimilar Players by Revenue (2016-2021)
- 3.3 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herceptin Biosimilar as of 2020)
- 3.4 Global Herceptin Biosimilar Average Price by Company (2016-2021)
- 3.5 Manufacturers Herceptin Biosimilar Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Herceptin Biosimilar Market Size by Type
- 4.1 Global Herceptin Biosimilar Historic Market Review by Type (2016-2021)
- 4.1.1 Global Herceptin Biosimilar Sales Market Share by Type (2016-2021)
- 4.1.2 Global Herceptin Biosimilar Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Herceptin Biosimilar Price by Type (2016-2021)
- 4.2 Global Herceptin Biosimilar Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Herceptin Biosimilar Sales Forecast by Type (2022-2027)
- 4.2.2 Global Herceptin Biosimilar Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Herceptin Biosimilar Price Forecast by Type (2022-2027)
5 Global Herceptin Biosimilar Market Size by Application
- 5.1 Global Herceptin Biosimilar Historic Market Review by Application (2016-2021)
- 5.1.1 Global Herceptin Biosimilar Sales Market Share by Application (2016-2021)
- 5.1.2 Global Herceptin Biosimilar Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Herceptin Biosimilar Price by Application (2016-2021)
- 5.2 Global Herceptin Biosimilar Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Herceptin Biosimilar Sales Forecast by Application (2022-2027)
- 5.2.2 Global Herceptin Biosimilar Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Herceptin Biosimilar Price Forecast by Application (2022-2027)
6 North America Herceptin Biosimilar Market Facts & Figures
- 6.1 North America Herceptin Biosimilar Sales by Company
- 6.1.1 North America Herceptin Biosimilar Sales by Company (2016-2021)
- 6.1.2 North America Herceptin Biosimilar Revenue by Company (2016-2021)
- 6.2 North America Herceptin Biosimilar Sales Breakdown by Type
- 6.2.1 North America Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 6.3 North America Herceptin Biosimilar Sales Breakdown by Application
- 6.3.1 North America Herceptin Biosimilar Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Herceptin Biosimilar Sales Breakdown by Application (2022-2027)
7 Europe Herceptin Biosimilar Market Facts & Figures
- 7.1 Europe Herceptin Biosimilar Sales by Company
- 7.1.1 Europe Herceptin Biosimilar Sales by Company (2016-2021)
- 7.1.2 Europe Herceptin Biosimilar Revenue by Company (2016-2021)
- 7.2 Europe Herceptin Biosimilar Sales Breakdown by Type
- 7.2.1 Europe Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 7.3 Europe Herceptin Biosimilar Sales Breakdown by Application
- 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Herceptin Biosimilar Market Facts & Figures
- 8.1 China Herceptin Biosimilar Sales by Company
- 8.1.1 China Herceptin Biosimilar Sales by Company (2016-2021)
- 8.1.2 China Herceptin Biosimilar Revenue by Company (2016-2021)
- 8.2 China Herceptin Biosimilar Sales Breakdown by Type
- 8.2.1 China Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 8.2.2 China Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 8.3 China Herceptin Biosimilar Sales Breakdown by Application
- 8.3.1 China 242 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Herceptin Biosimilar Market Facts & Figures
- 9.1 Japan Herceptin Biosimilar Sales by Company
- 9.1.1 Japan Herceptin Biosimilar Sales by Company (2016-2021)
- 9.1.2 Japan Herceptin Biosimilar Revenue by Company (2016-2021)
- 9.2 Japan Herceptin Biosimilar Sales Breakdown by Type
- 9.2.1 Japan Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 9.3 Japan Herceptin Biosimilar Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Herceptin Biosimilar Market Facts & Figures
- 10.1 Southeast Asia Herceptin Biosimilar Sales by Company
- 10.1.1 Southeast Asia Herceptin Biosimilar Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Herceptin Biosimilar Revenue by Company (2016-2021)
- 10.2 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type
- 10.2.1 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Herceptin Biosimilar Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Herceptin Biosimilar Market Facts & Figures
- 11.1 India Herceptin Biosimilar Sales by Company
- 11.1.1 India Herceptin Biosimilar Sales by Company (2016-2021)
- 11.1.2 India Herceptin Biosimilar Revenue by Company (2016-2021)
- 11.2 India Herceptin Biosimilar Sales Breakdown by Type
- 11.2.1 India Herceptin Biosimilar Sales Breakdown by Type (2016-2021)
- 11.2.2 India Herceptin Biosimilar Sales Breakdown by Type (2022-2027)
- 11.3 India Herceptin Biosimilar Sales Breakdown by Application
- 11.3.1 India Herceptin Biosimilar Sales Breakdown by Application (2016-2021)
- 11.3.2 India Herceptin Biosimilar Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Herceptin Biosimilar Business
- 12.1 Amgen
- 12.1.1 Amgen Corporation Information
- 12.1.2 Amgen Business Overview
- 12.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Amgen Herceptin Biosimilar Products Offered
- 12.1.5 Amgen Recent Development
- 12.2 AryoGen Biopharma
- 12.2.1 AryoGen Biopharma Corporation Information
- 12.2.2 AryoGen Biopharma Business Overview
- 12.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 AryoGen Biopharma Herceptin Biosimilar Products Offered
- 12.2.5 AryoGen Biopharma Recent Development
- 12.3 Biocon
- 12.3.1 Biocon Corporation Information
- 12.3.2 Biocon Business Overview
- 12.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Biocon Herceptin Biosimilar Products Offered
- 12.3.5 Biocon Recent Development
- 12.4 Celltrion
- 12.4.1 Celltrion Corporation Information
- 12.4.2 Celltrion Business Overview
- 12.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Celltrion Herceptin Biosimilar Products Offered
- 12.4.5 Celltrion Recent Development
- 12.5 Gedeon Richter
- 12.5.1 Gedeon Richter Corporation Information
- 12.5.2 Gedeon Richter Business Overview
- 12.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
- 12.5.5 Gedeon Richter Recent Development
- 12.6 Genor Biopharma
- 12.6.1 Genor Biopharma Corporation Information
- 12.6.2 Genor Biopharma Business Overview
- 12.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
- 12.6.5 Genor Biopharma Recent Development
- 12.7 Mabion
- 12.7.1 Mabion Corporation Information
- 12.7.2 Mabion Business Overview
- 12.7.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Mabion Herceptin Biosimilar Products Offered
- 12.7.5 Mabion Recent Development
- 12.8 Mylan
- 12.8.1 Mylan Corporation Information
- 12.8.2 Mylan Business Overview
- 12.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Mylan Herceptin Biosimilar Products Offered
- 12.8.5 Mylan Recent Development
- 12.9 Roche
- 12.9.1 Roche Corporation Information
- 12.9.2 Roche Business Overview
- 12.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Roche Herceptin Biosimilar Products Offered
- 12.9.5 Roche Recent Development
- 12.10 The Instituto Vital Brazil
- 12.10.1 The Instituto Vital Brazil Corporation Information
- 12.10.2 The Instituto Vital Brazil Business Overview
- 12.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 The Instituto Vital Brazil Herceptin Biosimilar Products Offered
- 12.10.5 The Instituto Vital Brazil Recent Development
13 Herceptin Biosimilar Manufacturing Cost Analysis
- 13.1 Herceptin Biosimilar Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Herceptin Biosimilar
- 13.4 Herceptin Biosimilar Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Herceptin Biosimilar Distributors List
- 14.3 Herceptin Biosimilar Customers
15 Market Dynamics
- 15.1 Herceptin Biosimilar Market Trends
- 15.2 Herceptin Biosimilar Drivers
- 15.3 Herceptin Biosimilar Market Challenges
- 15.4 Herceptin Biosimilar Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Herceptin Biosimilar . Industry analysis & Market Report on Herceptin Biosimilar is a syndicated market report, published as Global Herceptin Biosimilar Sales Market Report 2021. It is complete Research Study and Industry Analysis of Herceptin Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
